Back to Journals » Hepatic Medicine: Evidence and Research

Hepatic Medicine: Evidence and Research


Journal Articles:

- 88 records -

PNPLA3 expression and its impact on the liver: current perspectives

Bruschi FV, Tardelli M, Claudel T, Trauner M

Hepatic Medicine: Evidence and Research 2017, 9:55-66

Published Date: 6 November 2017

Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement

Tag-Adeen M, Sabra AM, Akazawa Y, Ohnita K, Nakao K

Hepatic Medicine: Evidence and Research 2017, 9:45-53

Published Date: 6 October 2017

Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:35-36

Published Date: 26 July 2017

Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt

Omar MZ, Metwally MA, El-Feky HM, Ahmed IA, Ismail MA, Idris A

Hepatic Medicine: Evidence and Research 2017, 9:27-33

Published Date: 14 June 2017

Hepatitis C infection in Egypt: prevalence, impact and management strategies

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:17-25

Published Date: 15 May 2017

Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain

Abdulla MA, Murad EA, Aljenaidi HA, Aljowder DR, Aljeeran OIK, Farid E, Al Qamish JR

Hepatic Medicine: Evidence and Research 2017, 9:7-11

Published Date: 1 March 2017

Unresectable hepatoblastoma: current perspectives

Trobaugh-Lotrario AD, Meyers RL, O'Neill AF, Feusner JH

Hepatic Medicine: Evidence and Research 2017, 9:1-6

Published Date: 1 February 2017

Targeted transplantation of mitochondria to hepatocytes

Gupta N, Wu CH, Wu GY

Hepatic Medicine: Evidence and Research 2016, 8:115-134

Published Date: 29 November 2016

Defibrotide in the treatment of hepatic veno-occlusive disease

Fulgenzi A, Ferrero ME

Hepatic Medicine: Evidence and Research 2016, 8:105-113

Published Date: 31 October 2016

Presence and consequence of tooth periapical radiolucency in patients with cirrhosis

Grønkjær LL, Holmstrup P, Schou S, Schwartz K, Kongstad J, Jepsen P, Vilstrup H

Hepatic Medicine: Evidence and Research 2016, 8:97-103

Published Date: 13 September 2016

Idiopathic noncirrhotic portal hypertension: current perspectives

Riggio O, Gioia S, Pentassuglio I, Nicoletti V, Valente M, d’Amati G

Hepatic Medicine: Evidence and Research 2016, 8:81-88

Published Date: 27 July 2016

Hepatitis C in the Russian Federation: challenges and future directions

Mukomolov S, Trifonova G, Levakova I, Bolsun D, Krivanogova E

Hepatic Medicine: Evidence and Research 2016, 8:51-60

Published Date: 5 May 2016

The pathophysiology of thrombocytopenia in chronic liver disease

Mitchell O, Feldman DM, Diakow M, Sigal SH

Hepatic Medicine: Evidence and Research 2016, 8:39-50

Published Date: 15 April 2016

Autophagy: a new target for nonalcoholic fatty liver disease therapy

Mao YQ, Yu FJ, Wang JB, Guo CY, Fan XM

Hepatic Medicine: Evidence and Research 2016, 8:27-37

Published Date: 24 March 2016

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response

Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T

Hepatic Medicine: Evidence and Research 2016, 8:9-20

Published Date: 22 February 2016

Challenging hepatitis C-infected liver transplant patients

Oliver M, Chiodo Ortiz C, Ortiz J

Hepatic Medicine: Evidence and Research 2016, 8:1-8

Published Date: 18 January 2016

Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil

Fabrício-Silva GM, Poschetzky BS, Perez RM, Santos RC, Cavalini LT, Porto LC

Hepatic Medicine: Evidence and Research 2015, 7:71-79

Published Date: 2 November 2015

Management options in decompensated cirrhosis

Shah NL, Banaei YP, Hojnowski KL, Cornella SL

Hepatic Medicine: Evidence and Research 2015, 7:43-50

Published Date: 15 July 2015

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs

Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M

Hepatic Medicine: Evidence and Research 2015, 7:37-42

Published Date: 13 July 2015

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease

Kawanaka M, Nishino K, Oka T, Urata N, Nakamura J, Suehiro M, Kawamoto H, Chiba Y, Yamada G

Hepatic Medicine: Evidence and Research 2015, 7:29-35

Published Date: 3 June 2015

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients

Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M

Hepatic Medicine: Evidence and Research 2015, 7:21-27

Published Date: 19 May 2015

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility

Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M

Hepatic Medicine: Evidence and Research 2015, 7:1-10

Published Date: 13 April 2015

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients

Vander Naalt SJ, Gurria JP, Holterman AXL

Hepatic Medicine: Evidence and Research 2014, 6:103-112

Published Date: 29 October 2014

Systemic vascular resistance in cirrhosis: a predictor of severity?

Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A

Hepatic Medicine: Evidence and Research 2014, 6:95-101

Published Date: 6 August 2014

Ending hepatitis C in the United States: the role of screening

Coffin PO, Reynolds A

Hepatic Medicine: Evidence and Research 2014, 6:79-87

Published Date: 3 July 2014

Transmission, diagnosis, and management of hepatitis E: an update

Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J

Hepatic Medicine: Evidence and Research 2014, 6:45-59

Published Date: 3 June 2014

Hepatitis C in Argentina: epidemiology and treatment

Gaite LA, Marciano S, Galdame OA, Gadano AC

Hepatic Medicine: Evidence and Research 2014, 6:35-43

Published Date: 27 May 2014

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease

Bradford V, Dillon JF, Miller MH

Hepatic Medicine: Evidence and Research 2014, 6:1-10

Published Date: 11 December 2013

A case of hepatic portal venous gas due to viral gastroenteritis

Mirmanesh M, Nguyen QS, Markelov A

Hepatic Medicine: Evidence and Research 2013, 5:63-65

Published Date: 21 October 2013

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients

Durango E, Dietrich C, Seitz HK, Kunz CU, Pomier-Layrargues GT, Duarte-Rojo A, Beaton M, Elkhashab M, Myers RP, Mueller S

Hepatic Medicine: Evidence and Research 2013, 5:43-52

Published Date: 4 July 2013

The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage

Ehnert S, Lukoschek T, Bachmann A, Martinez Sanchez JJ, Damm G, Nussler NC, Pscherer S, Stöckle U, Dooley S, Mueller S, Nussler AK

Hepatic Medicine: Evidence and Research 2013, 5:31-41

Published Date: 22 March 2013

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study

Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J, Hino K, Yamada G

Hepatic Medicine: Evidence and Research 2013, 5:11-16

Published Date: 4 March 2013

Natural history and management of primary biliary cirrhosis

Al-Harthy N, Kumagi T

Hepatic Medicine: Evidence and Research 2012, 4:61-71

Published Date: 4 December 2012

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina

Espul C, Benedetti L, Cuello H, Houillon G, Rasuli A

Hepatic Medicine: Evidence and Research 2012, 4:53-60

Published Date: 28 August 2012

Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites

Kohlhaas A, Durango E, Millonig G, Bastard C, Sandrin L, Golriz M, Mehrabi A, Büchler MW, Seitz HK, Mueller S

Hepatic Medicine: Evidence and Research 2012, 4:11-18

Published Date: 1 May 2012

Epidemiology and treatment of autoimmune hepatitis

Francque S, Vonghia L, Ramon A, Michielsen P

Hepatic Medicine: Evidence and Research 2012, 4:1-10

Published Date: 16 March 2012

Rifaximin in the treatment of hepatic encephalopathy

Iadevaia MD, Del Prete A, Cesaro C, Gaeta L, Zulli C, Loguercio C

Hepatic Medicine: Evidence and Research 2011, 3:109-117

Published Date: 22 December 2011

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program

Cervio G, Trentadue J, D´Agostino DE, Luque C, Giorgi MA, Armoni J, Debbag R

Hepatic Medicine: Evidence and Research 2011, 3:99-106

Published Date: 19 September 2011

Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH

Darwiche H, Oh S-H, Steiger-Luther NC, Williams JM, Pintilie DG, Shupe TD, Petersen BE

Hepatic Medicine: Evidence and Research 2011, 3:89-98

Published Date: 5 September 2011

Autonomic dysfunction in chronic liver disease

Frith J, Newton JL

Hepatic Medicine: Evidence and Research 2011, 3:81-87

Published Date: 23 August 2011

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Tomiyama Y, Yoshioka N, Yanai Y, Kawase T, Nishina S, Hara Y, Yoshida K, Korenaga K, Korenaga M, Hino K

Hepatic Medicine: Evidence and Research 2011, 3:45-52

Published Date: 26 April 2011

Erratum

Xiao N, Shi S, Zhuang H

Hepatic Medicine: Evidence and Research 2011, 3:19-20

Published Date: 18 March 2011

Pathogenesis and management of alcoholic liver cirrhosis: a review

Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao

Hepatic Medicine: Evidence and Research 2011, 3:1-11

Published Date: 24 December 2010

Update on new approaches in the management of hepatocellular carcinoma

Giuseppe Cabibbo, Michela Antonucci, Chiara Genco

Hepatic Medicine: Evidence and Research 2010, 2:163-172

Published Date: 26 November 2010

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma

Jen-Jung Pan, Milind Javle, Mie Mie Thinn, et al

Hepatic Medicine: Evidence and Research 2010, 2:147-155

Published Date: 2 November 2010

Potential treatment options and future research to increase hepatitis C virus treatment response rate

Veronica TenCate, Bruno Sainz Jr, Scott J Cotler, et al

Hepatic Medicine: Evidence and Research 2010, 2:125-145

Published Date: 1 October 2010

Optimal management of hepatorenal syndrome in patients with cirrhosis

Paolo Angeli, Filippo Morando

Hepatic Medicine: Evidence and Research 2010, 2:87-98

Published Date: 21 June 2010

Anti-inflammatory action of insulin via induction of Gadd45-β transcription by the mTOR signaling pathway

Katherine D Bortoff, Adam B Keeton, J Lee Franklin, et al

Hepatic Medicine: Evidence and Research 2010, 2:79-85

Published Date: 24 June 2010

Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis

Sumona Ghosh, Meenakshi Kaw, Payal R Patel, et al

Hepatic Medicine: Evidence and Research 2010, 2:69-78

Published Date: 31 May 2010

Liver stiffness: a novel parameter for the diagnosis of liver disease

Sebastian Mueller, Laurent Sandrin

Hepatic Medicine: Evidence and Research 2010, 2:49-67

Published Date: 25 May 2010

Mechanism of the inhibitory effect of ghrelin in sepsis

Asha Jacob, Rongqian Wu, Mian Zhou, et al

Hepatic Medicine: Evidence and Research 2010, 2:33-38

Published Date: 23 February 2010

Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes

Kathleen Ponzetti, Melissa King, Anna Gates, et al

Hepatic Medicine: Evidence and Research 2010, 2:1-11

Published Date: 11 January 2010

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

M Gabrovska, F Geurs, S Ponette, et al

Hepatic Medicine: Evidence and Research 2009, 1:9-12

Published Date: 30 October 2009

A high prevalence of extreme hyperferritinemia in acute hepatitis patients

Kazuhiro Kotoh, Akihiro Ueda, Masatake Tanaka, et al.

Hepatic Medicine: Evidence and Research 2009, 1:1-7

Published Date: 14 September 2009